LifeSci Capital discloses 7.9% in KALA BIO (KALA) ownership filing

Rhea-AI Filing Summary

LifeSci Capital LLC reported beneficial ownership of 2,200,000 shares of KALA BIO, Inc. common stock, representing 7.9% of the outstanding class. The percentage is based on 27,849,725 shares of common stock outstanding as of December 31, 2025, as referenced from a company prospectus.

LifeSci Capital has sole voting and dispositive power over these shares. Andrew McDonald and Michael Rice are listed as reporting persons with shared voting and dispositive power over the same 2,200,000 shares through LifeSci Capital, but each disclaims beneficial ownership except for any pecuniary interest. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of KALA BIO.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

KALA BIO, Inc.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title of Class of Securities)

483119202

(CUSIP Number)

12/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 483119202

1

Names of Reporting Persons

LifeSci Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,200,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,200,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,200,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.9 %

12

Type of Reporting Person (See Instructions)

BD

Comment for Type of Reporting Person: Ownership is based on 27,849,725 shares of Common Stock of the Issuer, as of December 31, 2025, according to the prospectus filed by the Company with the Securities and Exchange Commission on January 8, 2026.

SCHEDULE 13G

CUSIP No. 483119202

1

Names of Reporting Persons

Andrew McDonald

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,200,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,200,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,200,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.9 %

12

Type of Reporting Person (See Instructions)

BD

Comment for Type of Reporting Person: Solely as a manager of LifeSci Capital LLC, reporting person disclaims beneficial ownership except for any pecuniary ownership therein.

SCHEDULE 13G

CUSIP No. 483119202

1

Names of Reporting Persons

Michael Rice

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,200,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,200,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,200,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.9 %

12

Type of Reporting Person (See Instructions)

BD

Comment for Type of Reporting Person: Solely as a manager of LifeSci Capital LLC, reporting person disclaims beneficial ownership except for any pecuniary ownership therein.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: KALA BIO, Inc.
(b)	Address of issuer's principal executive offices: 1167 MASSACHUSETTS AVENUE, ARLINGTON, MASSACHUSETTS, 02476.
Item 2.
(a)	Name of person filing: LifeSci Capital LLC
(b)	Address or principal business office or, if none, residence: 1700 Broadway 40th Floor, New York, NY 10019
(c)	Citizenship: DELAWARE
(d)	Title of class of securities: Common Stock, $0.001 par value per share
(e)	CUSIP No.: 483119202
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G.
(b)	Percent of class: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G.
	(ii) Shared power to vote or to direct the vote: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G.
	(iii) Sole power to dispose or to direct the disposition of: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G.
	(iv) Shared power to dispose or to direct the disposition of: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

LifeSci Capital LLC

Signature:	/s/ Andrew McDonald
Name/Title:	Andrew McDonald, Chief Executive Officer
Date:	01/13/2026

Andrew McDonald

Signature:	/s/ Andrew McDonald
Name/Title:	Andrew McDonald
Date:	01/13/2026

Michael Rice

Signature:	/s/ Michael Rice
Name/Title:	Michael Rice
Date:	01/13/2026

FAQ

How many KALA (KALA BIO, Inc.) shares does LifeSci Capital LLC report owning?

LifeSci Capital LLC reports beneficial ownership of 2,200,000 shares of KALA BIO, Inc. common stock. It has sole voting and sole dispositive power over these shares.

What percentage of KALA BIO (KALA) does LifeSci Capital LLC beneficially own?

LifeSci Capital LLC reports beneficial ownership of 7.9% of KALA BIO, Inc.’s common stock, based on 27,849,725 shares outstanding as of December 31, 2025.

Who are the individual reporting persons in this KALA BIO (KALA) Schedule 13G?

The individual reporting persons are Andrew McDonald and Michael Rice. Each reports shared voting and shared dispositive power over the same 2,200,000 shares through LifeSci Capital LLC.

Do Andrew McDonald and Michael Rice claim full beneficial ownership of the KALA BIO shares?

No. Each states that, as a manager of LifeSci Capital LLC, they disclaim beneficial ownership of the KALA BIO shares except for any pecuniary interest they may have.

On what share count is LifeSci Capital’s 7.9% KALA BIO ownership based?

The 7.9% ownership figure is based on 27,849,725 shares of KALA BIO common stock outstanding as of December 31, 2025, as referenced from a company prospectus filed on January 8, 2026.

What does the Schedule 13G say about LifeSci Capital’s intent regarding control of KALA BIO (KALA)?

The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of KALA BIO, Inc.